Orthofix Medical Inc. Cost of Revenue
Orthofix Medical Inc. (OFIX) reported Cost of Revenue of $61.23 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-05
- Orthofix Medical Inc. cost of goods and services sold for the quarter ending 2026-06-30 was $61.23M, a 3.71% decline year-over-year.
- Orthofix Medical Inc. cost of goods and services sold for the quarter ending 2026-03-31 was $57.16M, a 20.64% decline year-over-year.
- Orthofix Medical Inc. cost of goods and services sold for the quarter ending 2025-12-31 was $63.57M, a 4.86% decline year-over-year.
- Orthofix Medical Inc. cost of goods and services sold for the quarter ending 2025-09-30 was $57.11M, a 7.22% decline year-over-year.
- Orthofix Medical Inc. cost of goods and services sold for fiscal 2025 was $256.30M, a 1.06% increase from fiscal 2024.
- Orthofix Medical Inc. cost of goods and services sold for fiscal 2024 was $253.61M, a 2.60% decline from fiscal 2023.
- Orthofix Medical Inc. cost of goods and services sold for fiscal 2023 was $260.37M, a 110.75% increase from fiscal 2022.
- Orthofix Medical Inc. cost of goods and services sold for fiscal 2022 was $123.54M, a 7.51% increase from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 3 month as first filed | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 6 month as first filed | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 9 month as first filed | Cost of Goods and Services Sold 12 month | Cost of Goods and Services Sold 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $61.23M 10-Q · filed 2026-08-05 | $118.39M 10-Q · filed 2026-08-05 | $181.96M derived: sum of 3 quarters · filed 2026-08-05 | $239.07M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | $57.16M 10-Q · filed 2026-05-05 | $120.73M derived: sum of 2 quarters · filed 2026-05-05 | $177.84M derived: sum of 3 quarters · filed 2026-05-05 | $241.43M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $63.57M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $120.68M derived: sum of 2 quarters · filed 2026-02-24 | $184.27M derived: sum of 3 quarters · filed 2026-08-05 | $256.30M 10-K · filed 2026-02-24 | ||||
| 2025-09-30 | $57.11M 10-Q · filed 2025-11-04 | $120.70M derived: sum of 2 quarters · filed 2026-08-05 | $192.73M 10-Q · filed 2025-11-04 | $259.54M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $63.59M 10-Q · filed 2026-08-05 | $135.62M 10-Q · filed 2026-08-05 | $202.43M derived: sum of 3 quarters · filed 2026-08-05 | $263.98M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | $72.03M 10-Q · filed 2026-05-05 | $138.84M derived: sum of 2 quarters · filed 2026-05-05 | $200.40M derived: sum of 3 quarters · filed 2026-05-05 | $264.27M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $66.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $128.37M derived: sum of 2 quarters · filed 2026-02-24 | $192.24M derived: sum of 3 quarters · filed 2026-02-24 | $253.61M 10-K · filed 2026-02-24 | ||||
| 2024-09-30 | $61.55M 10-Q · filed 2025-11-04 | $125.42M derived: sum of 2 quarters · filed 2025-11-04 | $186.79M 10-Q · filed 2025-11-04 | $250.57M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-06-30 | $63.87M 10-Q · filed 2025-08-05 | $125.24M 10-Q · filed 2025-08-05 | $189.02M derived: sum of 3 quarters · filed 2026-02-24 | $253.26M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-03-31 | $61.37M 10-Q · filed 2025-05-06 | $125.15M derived: sum of 2 quarters · filed 2026-02-24 | $189.39M derived: sum of 3 quarters · filed 2026-02-24 | $256.86M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2023-12-31 | $63.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $128.03M derived: sum of 2 quarters · filed 2026-02-24 | $195.49M derived: sum of 3 quarters · filed 2026-02-24 | $260.37M 10-K · filed 2026-02-24 | ||||
| 2023-09-30 | $64.24M 10-Q · filed 2024-11-07 | $131.71M derived: sum of 2 quarters · filed 2024-11-07 | $196.58M 10-Q · filed 2024-11-07 | $229.64M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-06-30 | $67.47M 10-Q · filed 2024-08-06 | $132.34M 10-Q · filed 2024-08-06 | $165.39M derived: sum of 3 quarters · filed 2025-02-25 | $195.97M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-03-31 | $64.88M 10-Q · filed 2024-05-07 | $97.93M derived: sum of 2 quarters · filed 2025-02-25 | $128.50M derived: sum of 3 quarters · filed 2025-02-25 | $160.10M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2022-12-31 | $33.05M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $63.63M derived: sum of 2 quarters · filed 2025-02-25 | $95.23M derived: sum of 3 quarters · filed 2025-02-25 | $123.54M 10-K · filed 2025-02-25 | ||||
| 2022-09-30 | $30.57M 10-Q · filed 2023-11-08 | $62.17M derived: sum of 2 quarters · filed 2023-11-08 | $90.49M 10-Q · filed 2023-11-08 | $123.75M derived: sum of 4 quarters · filed 2024-03-05 | ||||
| 2022-06-30 | $31.60M 10-Q · filed 2023-08-08 | $59.92M 10-Q · filed 2023-08-08 | $93.17M derived: sum of 3 quarters · filed 2024-03-05 | $121.48M derived: sum of 4 quarters · filed 2024-03-05 | ||||
| 2022-03-31 | $28.32M 10-Q · filed 2023-05-09 | $61.57M derived: sum of 2 quarters · filed 2024-03-05 | $89.88M derived: sum of 3 quarters · filed 2024-03-05 | $117.32M derived: sum of 4 quarters · filed 2024-03-05 | ||||
| 2021-12-31 | $33.25M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $61.56M derived: sum of 2 quarters · filed 2024-03-05 | $89.00M derived: sum of 3 quarters · filed 2024-03-05 | $114.91M 10-K · filed 2024-03-05 | ||||
| 2021-09-30 | $28.31M 10-Q · filed 2022-11-03 | $55.75M derived: sum of 2 quarters · filed 2022-11-03 | $81.66M 10-Q · filed 2022-11-03 | $110.73M derived: sum of 4 quarters · filed 2023-03-06 | ||||
| 2021-06-30 | $27.44M 10-Q · filed 2022-08-05 | $53.35M 10-Q · filed 2022-08-05 | $82.42M derived: sum of 3 quarters · filed 2023-03-06 | $108.67M derived: sum of 4 quarters · filed 2023-03-06 | ||||
| 2021-03-31 | $25.91M 10-Q · filed 2022-05-06 | $54.98M derived: sum of 2 quarters · filed 2023-03-06 | $81.23M derived: sum of 3 quarters · filed 2023-03-06 | $104.39M derived: sum of 4 quarters · filed 2023-03-06 | ||||
| 2020-12-31 | $29.07M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $55.31M derived: sum of 2 quarters · filed 2023-03-06 | $78.48M derived: sum of 3 quarters · filed 2023-03-06 | $101.89M 10-K · filed 2023-03-06 | ||||
| 2020-09-30 | $26.24M 10-Q · filed 2021-11-05 | $49.41M derived: sum of 2 quarters · filed 2021-11-05 | $72.82M 10-Q · filed 2021-11-05 | $99.01M derived: sum of 4 quarters · filed 2021-11-05 | ||||
| 2020-06-30 | $23.17M 10-Q · filed 2021-08-06 | $46.58M 10-Q · filed 2021-08-06 | $72.77M derived: sum of 3 quarters · filed 2021-08-06 | $97.66M derived: sum of 4 quarters · filed 2021-08-06 | ||||
| 2020-03-31 | $23.41M 10-Q · filed 2021-04-30 | $49.60M derived: sum of 2 quarters · filed 2021-04-30 | $74.50M derived: sum of 3 quarters · filed 2021-04-30 | $100.31M derived: sum of 4 quarters · filed 2021-04-30 | ||||
| 2019-12-31 | $26.19M 10-K · filed 2020-02-24 | $51.09M derived: sum of 2 quarters · filed 2020-11-05 | $76.90M derived: sum of 3 quarters · filed 2020-11-05 | $100.61M 10-K · filed 2022-02-25 | ||||
| 2019-09-30 | $24.90M 10-Q · filed 2020-11-05 | $50.71M derived: sum of 2 quarters · filed 2020-11-05 | $74.42M 10-Q · filed 2020-11-05 | $100.04M derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | $25.81M 10-Q · filed 2020-08-06 | $49.52M 10-Q · filed 2020-08-06 | $75.15M derived: sum of 3 quarters · filed 2020-08-06 | $99.17M derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | $23.71M 10-Q · filed 2020-05-08 | $49.33M derived: sum of 2 quarters · filed 2020-05-08 | $73.35M derived: sum of 3 quarters · filed 2020-05-08 | $96.19M derived: sum of 4 quarters · filed 2020-05-08 | ||||
| 2018-12-31 | $25.63M 10-K · filed 2020-02-24 | $49.65M derived: sum of 2 quarters · filed 2020-02-24 | $72.48M derived: sum of 3 quarters · filed 2020-02-24 | $96.63M 10-K · filed 2021-02-26 | ||||
| 2018-09-30 | $24.02M 10-K · filed 2020-02-24 | $46.85M derived: sum of 2 quarters · filed 2020-02-24 | $71.00M 10-Q · filed 2019-10-28 | $94.56M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-06-30 | $22.84M 10-K · filed 2020-02-24 | $46.98M 10-Q · filed 2019-08-05 | $70.54M derived: sum of 3 quarters · filed 2020-02-24 | $94.26M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-03-31 | $24.15M 10-K · filed 2020-02-24 | $47.71M derived: sum of 2 quarters · filed 2020-02-24 | $71.43M derived: sum of 3 quarters · filed 2020-02-24 | $94.60M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2017-12-31 | $23.56M 10-K · filed 2019-02-25 | $47.28M derived: sum of 2 quarters · filed 2019-02-25 | $70.46M derived: sum of 3 quarters · filed 2019-02-25 | $93.04M 10-K · filed 2020-02-24 | ||||
| 2017-09-30 | $23.72M 10-K · filed 2019-02-25 | $46.89M derived: sum of 2 quarters · filed 2019-02-25 | $69.47M 10-Q · filed 2018-10-29 | $92.80M derived: sum of 4 quarters · filed 2019-02-25 | ||||
| 2017-06-30 | $23.18M 10-K · filed 2019-02-25 | $45.76M 10-Q · filed 2018-08-06 | $69.08M derived: sum of 3 quarters · filed 2019-02-25 | $88.96M derived: sum of 4 quarters · filed 2019-02-25 | ||||
| 2017-03-31 | $22.58M 10-K · filed 2019-02-25 | $45.90M derived: sum of 2 quarters · filed 2019-02-25 | $65.78M derived: sum of 3 quarters · filed 2019-02-25 | $88.30M derived: sum of 4 quarters · filed 2019-02-25 | ||||
| 2016-12-31 | $23.32M 10-K · filed 2018-02-26 | $43.20M derived: sum of 2 quarters · filed 2018-02-26 | $65.72M derived: sum of 3 quarters · filed 2018-02-26 | $87.85M 10-K · filed 2019-02-25 | ||||
| 2016-09-30 | $19.88M 10-K · filed 2018-02-26 | $42.40M derived: sum of 2 quarters · filed 2018-02-26 | $64.53M 10-Q · filed 2017-10-30 | $85.94M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2016-06-30 | $22.52M 10-K · filed 2018-02-26 | $22.52M 10-Q · filed 2016-08-01 | $44.65M 10-Q · filed 2017-08-07 | $44.65M 10-Q · filed 2016-08-01 | $66.06M derived: sum of 3 quarters · filed 2018-02-26 | $89.93M derived: sum of 4 quarters · filed 2018-02-26 | ||
| 2016-03-31 | $22.14M 10-K · filed 2018-02-26 | $22.14M 10-Q · filed 2016-04-28 | $43.55M derived: sum of 2 quarters · filed 2018-02-26 | $67.41M derived: sum of 3 quarters · filed 2018-02-26 | $89.32M derived: sum of 4 quarters · filed 2018-02-26 | |||
| 2015-12-31 | $21.41M 10-K · filed 2017-02-27 | $45.28M derived: sum of 2 quarters · filed 2017-02-27 | $67.19M derived: sum of 3 quarters · filed 2017-02-27 | $86.53M 10-K · filed 2018-02-26 | ||||
| 2015-09-30 | $23.86M 10-K · filed 2017-02-27 | $45.77M derived: sum of 2 quarters · filed 2017-02-27 | $65.11M 10-Q · filed 2016-10-31 | $86.57M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-06-30 | $21.91M 10-K · filed 2017-02-27 | $41.25M 10-Q · filed 2016-08-01 | $62.71M derived: sum of 3 quarters · filed 2017-02-27 | $87.97M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-03-31 | $19.34M 10-K · filed 2017-02-27 | $40.80M derived: sum of 2 quarters · filed 2017-02-27 | $66.06M derived: sum of 3 quarters · filed 2017-02-27 | $91.48M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2014-12-31 | $21.46M 10-K · filed 2016-02-29 | $46.73M derived: sum of 2 quarters · filed 2016-02-29 | $72.14M derived: sum of 3 quarters · filed 2016-02-29 | $98.91M 10-K · filed 2017-02-27 | ||||
| 2014-09-30 | $25.27M 10-K · filed 2016-02-29 | $50.68M derived: sum of 2 quarters · filed 2016-02-29 | $77.45M 10-Q · filed 2015-11-03 | $111.58M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | $25.41M 10-K · filed 2016-02-29 | $52.19M 10-Q · filed 2015-08-04 | $86.31M derived: sum of 3 quarters · filed 2016-02-29 | $111.37M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | $26.77M 10-K · filed 2016-02-29 | $22.63M 10-Q · filed 2014-05-08 | $60.90M derived: sum of 2 quarters · filed 2016-02-29 | $85.96M derived: sum of 3 quarters · filed 2016-02-29 | $107.84M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2013-12-31 | $34.12M 10-K · filed 2015-04-29 | $32.52M 10-K · filed 2014-03-31 | $59.19M derived: sum of 2 quarters · filed 2015-04-29 | $81.07M derived: sum of 3 quarters · filed 2015-04-29 | $106.91M 10-K · filed 2016-02-29 | $102.30M 10-K · filed 2014-03-31 | ||
| 2013-09-30 | $25.06M 10-K · filed 2015-04-29 | $23.92M 10-Q · filed 2014-03-25 | $46.95M derived: sum of 2 quarters · filed 2015-04-29 | $72.79M 10-Q · filed 2015-03-31 | $69.78M 10-Q · filed 2014-03-25 | $99.54M derived: sum of 4 quarters · filed 2015-04-29 | ||
| 2013-06-30 | $21.88M 10-K · filed 2015-04-29 | $20.25M 10-Q · filed 2014-03-24 | $47.73M 10-Q · filed 2015-03-31 | $45.86M 10-Q · filed 2014-03-24 | $74.48M derived: sum of 3 quarters · filed 2015-04-29 | $99.36M derived: sum of 4 quarters · filed 2015-04-29 | ||
| 2013-03-31 | $25.84M 10-K · filed 2015-04-29 | $22.70M 10-Q · filed 2013-05-09 | $52.59M derived: sum of 2 quarters · filed 2015-04-29 | $77.48M derived: sum of 3 quarters · filed 2015-04-29 | $102.42M derived: sum of 4 quarters · filed 2015-04-29 | |||
| 2012-12-31 | $26.75M 10-K/A · filed 2015-03-31 | $24.94M 10-K/A · filed 2014-03-24 | $51.64M derived: sum of 2 quarters · filed 2015-03-31 | $76.58M derived: sum of 3 quarters · filed 2015-03-31 | $100.73M 10-K · filed 2015-04-29 | $86.49M 10-K · filed 2013-03-01 | ||
| 2012-09-30 | $24.89M 10-K/A · filed 2015-03-31 | $22.37M 10-Q · filed 2012-11-02 | $49.83M derived: sum of 2 quarters · filed 2015-03-31 | $73.31M 10-Q · filed 2014-03-25 | $67.99M 10-Q · filed 2012-11-02 | $101.28M derived: sum of 4 quarters · filed 2015-03-31 | ||
| 2012-06-30 | $24.94M 10-K/A · filed 2015-03-31 | $23.68M 10-Q · filed 2012-07-30 | $48.92M 10-Q · filed 2014-03-24 | $45.62M 10-Q · filed 2012-07-30 | $76.39M derived: sum of 3 quarters · filed 2015-03-31 | $99.51M derived: sum of 4 quarters · filed 2015-03-31 | ||
| 2012-03-31 | $24.14M 10-K/A · filed 2015-03-31 | $32.88M 10-Q · filed 2012-05-04 | $51.45M derived: sum of 2 quarters · filed 2015-03-31 | $74.57M derived: sum of 3 quarters · filed 2015-03-31 | $97.33M derived: sum of 4 quarters · filed 2015-03-31 | |||
| 2011-12-31 | $27.30M 10-K/A · filed 2014-03-24 | $50.43M derived: sum of 2 quarters · filed 2014-03-24 | $73.18M derived: sum of 3 quarters · filed 2014-03-24 | $96.42M 10-K/A · filed 2015-03-31 | $139.19M 10-K · filed 2012-02-29 | |||
| 2011-09-30 | $23.13M 10-K/A · filed 2014-03-24 | $36.03M 10-Q · filed 2011-10-31 | $45.88M derived: sum of 2 quarters · filed 2014-03-24 | $69.38M 10-Q · filed 2012-11-02 | $104.08M 10-Q · filed 2011-10-31 | $66.27M derived: sum of 4 quarters · filed 2014-03-24 | ||
| 2011-06-30 | $22.75M 10-K/A · filed 2014-03-24 | $34.69M 10-Q · filed 2011-08-05 | $45.53M 10-Q · filed 2012-07-30 | $68.05M 10-Q · filed 2011-08-05 | $43.15M derived: sum of 3 quarters · filed 2014-03-24 | $75.41M derived: sum of 4 quarters · filed 2014-03-24 | ||
| 2011-03-31 | $22.35M 10-K/A · filed 2014-03-24 | $33.36M 10-Q · filed 2012-05-04 | $20.39M derived: sum of 2 quarters · filed 2014-03-24 | $52.66M derived: sum of 3 quarters · filed 2014-03-24 | $86.75M derived: sum of 4 quarters · filed 2014-03-24 | |||
| 2010-12-31 | -$1.95M derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-03-24 | $30.31M derived: sum of 2 quarters · filed 2014-03-24 | $64.40M derived: sum of 3 quarters · filed 2014-03-24 | $97.09M 10-K/A · filed 2014-03-24 | $131.72M 10-K · filed 2012-02-29 | |||
| 2010-09-30 | $32.27M 10-Q · filed 2011-10-31 | $66.35M derived: sum of 2 quarters · filed 2011-10-31 | $99.05M 10-Q · filed 2011-10-31 | |||||
| 2010-06-30 | $34.09M 10-Q · filed 2011-08-05 | $66.78M 10-Q · filed 2011-08-05 | ||||||
| 2009-12-31 | $138.45M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |